Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06118554 · ClinicalTrials.gov registry record · NA
3D Printing to Improve Nasal Irrigation Outcome
A NA study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis Without Nasal Polyps, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06118554: Recruiting NA study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis Without Nasal Polyps, sponsored by Ohio State University.
NCT06118554 is a NA study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis Without Nasal Polyps that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 200 participants, above the 124-participant average among 11 other Chronic Rhinosinusitis With Nasal Polyps trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06118554, a NA study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis Without Nasal Polyps, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Three-dimensional (3D) printing has been an emerging technology with uses in a wide array of fields. This research aims to use 3D printing as a tool to provide personalized education to maximize treatment efficacy based on the patient's individual anatomy. With increased irrigation to the sinuses, we hypothesize there will be improved patient satisfaction and higher quality of life. The outcomes of this research could lead to a new option for patients who live with chronic rhinosinusitis are not candidates for surgery or are interested in less invasive options. The 3D printed nasal replica is not something that would be implanted, rather it is a hand-held device used specifically for participants to better understand their nasal anatomy.
Primary Outcome
patient-reported outcome measure
Conditions Studied
Interventions
- OTHER Irrigation head position
Study Locations (1)
Ohio
- The Ohio State University Eye and Ear Institue - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What NCT06118554 shows while recruiting
NCT06118554 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 124-participant average among 11 other Chronic Rhinosinusitis With Nasal Polyps trials with a reported enrollment target (61% higher).
The record links to 2 conditions, with Chronic Rhinosinusitis With Nasal Polyps appearing as the primary indexed condition, and to 1 intervention - of which Irrigation head position is the first listed.
NCT06118554 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06118554 about?
NCT06118554 is a clinical study titled "3D Printing to Improve Nasal Irrigation Outcome". Three-dimensional (3D) printing has been an emerging technology with uses in a wide array of fields. This research aims to use 3D printing as a tool to provide personalized education to maximize treatment efficacy based on the patient's individual anatomy. With increased irrigation to the sinuses, w...
What is the current status of trial NCT06118554?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-11-01. Estimated completion is 2027-12-30.
What conditions does trial NCT06118554 study?
This clinical trial studies the following conditions: Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis Without Nasal Polyps.
What interventions are being tested in trial NCT06118554?
The interventions under investigation include: Irrigation head position (OTHER).
Who is sponsoring clinical trial NCT06118554?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06118554 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinosinusitis With Nasal Polyps
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06118554's enrollment target sits among peer trials
200 4th of 11 higher than 8 of 11 other Chronic Rhinosinusitis With Nasal Polyps trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Rhinosinusitis With Nasal Polyps trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
RECRUITING · Phase 3
-
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study
RECRUITING · Phase 2
-
The Role of IL5 in Epithelial Cell Integrity
RECRUITING · Early Phase 1
-
A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
RECRUITING · Phase 3
-
Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
RECRUITING
-
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI